Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-02-20 @ 6:45 PM
Study NCT ID:
NCT00524667
Status:
TERMINATED
Last Update Posted:
2011-07-20
First Post:
2007-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia
Sponsor:
CancerCare Manitoba
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CCM-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. David Szwajcer, Principal Investigator
Old Organization:
CancerCare Manitoba
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |